Optimization of Diarylamines as Non‐Nucleoside Inhibitors of HIV‐1 Reverse Transcriptase.

Juliana Ruiz‐Caro; Aravind Basavapathruni; Joseph T. Kim; Christopher M. Bailey; Ligong Wang; Karen S. Anderson; Andrew D. Hamilton; William L. Jorgensen

doi:10.1002/chin.200618152

Optimization of Diarylamines as Non‐Nucleoside Inhibitors of HIV‐1 Reverse Transcriptase.

ChemInform 37(18)

Article 2006 English

Abstract

1 min read

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2007

Discovery of Novel Benzimidazolones as Potent Non‐Nucleoside Reverse Transcriptase Inhibitors Active Against Wild‐Type and Mutant HIV‐1 Strains.

Maria Letizia Barreca, Angela Rao, Laura De Luca, Nunzio Iraci, Anna‐Maria Monforte, Giovanni Maga, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Alba Chimirri

Article2007

Synthesis and anti‐HIV Activity Evaluation of 1‐[(Alkenyl or Alkynyl or Alkyloxy)methyl]‐5‐alkyl‐6‐(1‐naphthoyl)‐2,4‐pyrimidinediones as Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.

Lei Li, Fen‐Er Chen, Bin Xie, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2007

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐Naphthoyl) HEPT Analogues.

Lei Ji, Fen‐Er Chen, Xiaoqing Feng, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2007

Synthesis and anti‐HIV Activity of Novel Cyclopentenyl Nucleoside Analogues of 8‐Azapurine.

Pilar Canoa, María J. González‐Moa, Marta Teijeira, Carmen Terán, Eugenio Uriarte, Christophe Pannecouque, De Clercq Erik

Article2006

The Regulation of HIV‐1 Transcription: Molecular Targets for Chemotherapeutic Intervention

Miguel Stevens, De Clercq Erik, Jan Balzarini